The invention discloses a trelagliptin impurity compound, an impurity compound-containing composition which is a trelagliptin bulk drug, and an application of the impurity compound for controlling mass of trelagliptin.
-
Paragraph 0021
(2016/11/17)
More Articles about upstream products of 1917324-13-0
Get Best Price for1917324-13-0(R)-2-((6-(3-((3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile